Gaithersburg, MD, United States of America

Pharmavene, Inc.

Calculating rank

USPTO Granted Patents = 5

Forward Citations = 280

Loading Chart...

5 inventors (with patents filed for the assignee):

Edward M Rudnic (4 out of 48 patents)

John A McCarty (3 out of 22 patents)

George W Belenduik (3 out of 3 patents)

4. Thomas J Lynch (1 out of 1 patent)

5. George W Belendiuk (1 out of 3 patents)

5 patents: Sort by Forward Citations

1. 5484608 - Sustained-release drug delivery system (1996-01-16),

2. 5447729 - Multilamellar drug delivery systems (1995-09-05),

3. 5430021 - Hydrophobic drug delivery systems (1995-07-04),

4. 5326570 - Advanced drug delivery system and method of treating psychiatric, (1994-07-05),

5. 5272080 - Production of butyrylcholinesterase (1993-12-21),

Company Overview

Pharmavene, Inc. is a pharmaceutical company that specializes in the research, development, and production of innovative medications. With a focus on improving patient outcomes and enhancing quality of life, Pharmavene is committed to delivering high-quality and affordable healthcare solutions. Our dedicated team of experts works tirelessly to bring cutting-edge treatments to market and address unmet medical needs. Visit our website to learn more about our innovative products and pipeline of future therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

5 Patents

#74 in Gaithersburg, MD

#752 in Maryland

#51,708 in US

Gaithersburg, MD, United States of America

Pharmavene, Inc.

Forward Citations = 280

5 inventors:

Edward M Rudnic (4 out of 48 patents)

John A McCarty (3 out of 22 patents)

George W Belenduik (3 out of 3 patents)

4. Thomas J Lynch (1 out of 1 patent)

5. George W Belendiuk (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pharmavene, Inc.. Retrieved from https://idiyas.com/company/pharmavene

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]